NCT Number: NCT02463617
Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study
This study aims to characterize the nature of impulsivity in Parkinson's Disease (PD).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Pascal DERKINDEREN, Nantes, France
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Early onset PD patients and late onset PD patients with siblings available PD patients with or without impulse control disorders Current or past treatment with dopamine agonists or levodopa PD patients without dementia Age < 80 ans
Exclusion criteria
Early onset PD patients and late onset PD patients without siblings available PD patients with dementia Age > 80 years
Treatment and study plan
Primary outcomes
-
Barratt Impulsiveness Scale
Time frame: up to three months
Sponsors and collaborators
Lead sponsor
Poitiers University Hospital
Other
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2021
- Study completion
- 2021
- First posted
- Jun 4, 2015
- Registry last updated
- Oct 5, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Clinical Laboratory Evaluation of Chronic Autonomic Failure
NCT03648905
Autonomic Failure, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsAAV2-GDNF for Advanced Parkinson s Disease
NCT01621581
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsPre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
NCT05699460
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Irvine, California, United States
View Trial DetailsEffects of Wild Blueberry Ingestion on Motor Performance of People With Parkinson's Disease
NCT07720869
Basal Ganglia Diseases, Brain Diseases
Baton Rouge, Louisiana, United States
View Trial Details